Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 6.4.2020 | EN | Official Journal of the European Union | C 114/18 |

---

Action brought on 20 February 2020 — Biochange Group v EUIPO — Laubender (medical beauty research)

(Case T-98/20)

(2020/C 114/20)

Language in which the application was lodged: German

Parties

Applicant: Biochange Group GmbH (Bad Schlema, Germany) (represented by: C. König, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Laubender GmbH (Vienna, Austria)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘medical beauty research’ — EU trade mark No 4 215 935

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 8 November 2019 in Case R 114/2019-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO and Laubender GmbH, if it should intervene in these proceedings, to pay the costs of the present proceedings and of the appeal proceedings. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 7(1)(c) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

|  |  |
| --- | --- |
| — | Infringement of the second sentence of Article 95(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)